Gorski JC - Search Results

1

The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.

Gorski JC, Vannaprasaht S, Hamman MA, Ambrosius WT, Bruce MA, Haehner-Daniels B, Hall SD. Gorski JC, et al. Clin Pharmacol Ther. 2003 Sep;74(3):275-87. doi: 10.1016/S0009-9236(03)00187-5. Clin Pharmacol Ther. 2003. PMID: 12966371 Clinical Trial.

2

The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity.

Ward BA, Gorski JC, Jones DR, Hall SD, Flockhart DA, Desta Z. Ward BA, et al. Among authors: gorski jc. J Pharmacol Exp Ther. 2003 Jul;306(1):287-300. doi: 10.1124/jpet.103.049601. Epub 2003 Apr 3. J Pharmacol Exp Ther. 2003. PMID: 12676886

3

The interaction between St John's wort and an oral contraceptive.

Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ, Hilligoss JK, Miller M, Gorski JC. Hall SD, et al. Among authors: gorski jc. Clin Pharmacol Ther. 2003 Dec;74(6):525-35. doi: 10.1016/j.clpt.2003.08.009. Clin Pharmacol Ther. 2003. PMID: 14663455 Clinical Trial.

4

The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo.

Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA, Desai M, Miller M, Hall SD. Gorski JC, et al. Clin Pharmacol Ther. 2004 Jan;75(1):89-100. doi: 10.1016/j.clpt.2003.09.013. Clin Pharmacol Ther. 2004. PMID: 14749695

5

Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression.

Pinto AG, Wang YH, Chalasani N, Skaar T, Kolwankar D, Gorski JC, Liangpunsakul S, Hamman MA, Arefayene M, Hall SD. Pinto AG, et al. Among authors: gorski jc. Clin Pharmacol Ther. 2005 Mar;77(3):178-88. doi: 10.1016/j.clpt.2004.10.002. Clin Pharmacol Ther. 2005. PMID: 15735612 Clinical Trial.

6

The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates.

Lemma GL, Wang Z, Hamman MA, Zaheer NA, Gorski JC, Hall SD. Lemma GL, et al. Among authors: gorski jc. Clin Pharmacol Ther. 2006 Mar;79(3):218-30. doi: 10.1016/j.clpt.2005.11.001. Epub 2006 Feb 7. Clin Pharmacol Ther. 2006. PMID: 16513446 Clinical Trial.

7

Interaction between midazolam and clarithromycin in the elderly.

Quinney SK, Haehner BD, Rhoades MB, Lin Z, Gorski JC, Hall SD. Quinney SK, et al. Among authors: gorski jc. Br J Clin Pharmacol. 2008 Jan;65(1):98-109. doi: 10.1111/j.1365-2125.2007.02970.x. Epub 2007 Jul 17. Br J Clin Pharmacol. 2008. PMID: 17635500 Free PMC article. Clinical Trial.

8

Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin.

Quinney SK, Malireddy SR, Vuppalanchi R, Hamman MA, Chalasani N, Gorski JC, Hall SD. Quinney SK, et al. Among authors: gorski jc. Eur J Clin Pharmacol. 2013 Mar;69(3):439-48. doi: 10.1007/s00228-012-1339-x. Epub 2012 Jul 10. Eur J Clin Pharmacol. 2013. PMID: 22777148 Free PMC article. Clinical Trial.

9

Induction of multidrug resistance-1 and cytochrome P450 mRNAs in human mononuclear cells by rifampin.

Asghar A, Gorski JC, Haehner-Daniels B, Hall SD. Asghar A, et al. Among authors: gorski jc. Drug Metab Dispos. 2002 Jan;30(1):20-6. doi: 10.1124/dmd.30.1.20. Drug Metab Dispos. 2002. PMID: 11744607

10

Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily.

Gorski JC, Jones DR, Wrighton SA, Hall SD. Gorski JC, et al. Biochem Pharmacol. 1994 Jul 5;48(1):173-82. doi: 10.1016/0006-2952(94)90237-2. Biochem Pharmacol. 1994. PMID: 8043020

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page